TGFB1 and neoplasm: This phenotype aligns with known mechanisms of immune suppression, including that driven by TGF-β through ECM remodeling47, and metabolic reprogramming and reduction in arginine, along with the secretion of ornithine by tumor-associated macrophages47 that suppress T cell functions.